Project ALS is concerned by proposed cuts to the National Institutes of Health (NIH).
Science is our most powerful tool in the fight against disease. NIH funding— over $47 billion annually— has been vital in advancing ALS research, including at the Project ALS Therapeutics Core. Thanks to NIH funding, Project ALS has been able to take a laser-focused approach to ALS research programs and the pursuit of ambitious blue-sky initiatives.
While Project ALS research currently remains on track, it will be extraordinarily difficult to keep pace with our progress if the planned cuts to NIH become reality.
The NIH is the vital ecosystem within which the United States has become a global leader in healthcare and drug development. The proposed cuts threaten critical preclinical and clinical research, and would disrupt the entire drug development pipeline that people living with ALS rely on for access to potential therapies.
We urge you to contact your local representatives—people living with ALS, and anyone affected by disease, deserve better.
The ALS Association has created a resource to connect you with your Members of Congress: als.quorum.us/campaign/Fight-Funding-Cuts/.
To learn more about the NIH budget and grant-making process, visit grants.nih.gov/grants-process or nih.gov/about-nih/what-we-do/budget.
Project ALS remains committed to full transparency as this situation unfolds, and to our mission: finding a cure for ALS.
